The global histone modification pattern correlates with overall survival in metachronous liver metastasis of colorectal cancer

Oncology Reports

Volumn 27, Issue 3, 2012, Pages 637-642

  Tamagawa, Hiroshi ^a   Oshima, Takashi ^b   Shiozawa, Manabu ^a   Morinaga, Soichiro ^a   Nakamura, Yoshiyasu ^a   Yoshihara, Mitsuyo ^a   Sakuma, Yuji ^a   Kameda, Yoichi ^a   Akaike, Makoto ^a   Masuda, Munetaka ^c   Imada, Toshio ^c   Miyagi, Yohei ^a  

^a KANAGAWA CANCER CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; H3K4; H3K9; Histone modification; Immunohistochemistry; Liver metastasis; Prognostic factor

Indexed keywords

HISTONE H3; HISTONE H3 LYSINE 4; HISTONE H3 LYSINE 9; UNCLASSIFIED DRUG;

ADULT; AGE; ARTICLE; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; GENDER; HISTONE ACETYLATION; HISTONE DIMETHYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER HISTOLOGY; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METACHRONOUS LIVER METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TUMOR VOLUME;

ACETYLATION; COLORECTAL NEOPLASMS; FEMALE; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYSINE; MALE; METHYLATION; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84856305581     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2011.1547     Document Type: Article

References (27)

1. Weitz J, Koch M, Debus J, Hohler T, Galle PR and Buchler MW: Colorectal cancer. Lancet 365: 153-165, 2005. (Pubitemid 40091806)
2. Homsi J and Garrett CR: Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer. Cancer Control 13: 42-47, 2006. (Pubitemid 43327553)
3. Yasui W, Sentani K, Motoshita J and Nakayama H: Molecular pathobiology of gastric cancer. Scand J Surg 95: 225-231, 2006. (Pubitemid 46089255)
4. Kurdistani SK: Histone modifications as markers of cancer prognosis: a cellular view. Br J Cancer 97: 1-5, 2007.
5. Seligson DB, Horvath S, Shi T, et al: Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262-1266, 2005. (Pubitemid 40943093)
6. Seligson DB, Horvath S, McBrian MA, et al: Global levels of histone modifications predict prognosis in different cancers. Am J Pathol 174: 1619-1628, 2009.
7. Barlesi F, Giaccone G, Gallegos-Ruiz MI, et al: Global histone modifications predict prognosis of resected non-small cell lung cancer. J Clin Oncol 25: 4358-4364, 2007. (Pubitemid 350013840)
8. Van Den Broeck A, Brambilla E, Moro-Sibilot D, et al: Loss of histone H4K20 trimethylation occurs in preneoplasia and influences prognosis of non-small cell lung cancer. Clin Cancer Res 14: 7237-7245, 2008.
9. Park YS, Jin MY, Kim YJ, Yook JH, Kim BS and Jang SJ: The global histone modification pattern correlates with cancer recurrence and overall survival in gastric adenocarcinoma. Ann Surg Oncol 15: 1968-1976, 2008.
10. Wei Y, Xia W, Zhang Z, et al: Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers. Mol Carcinog 47: 701-706, 2008.
11. Manuyakorn A, Paulus R, Farrell J, et al: Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J Clin Oncol 28: 1358-1365, 2010.
12. Toh Y, Yamamoto M, Endo K, et al: Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep 10: 333-338, 2003.
13. I H, Ko E, Kim Y, et al: Association of global levels of histone modifications with recurrence-free survival in stage IIB and III esophageal squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 19: 566-573, 2010.
14. Elsheikh SE, Green AR, Rakha EA, et al: Global histone modi- fications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res 69: 3802-3809, 2009.
15. Kondo Y, Shen L and Issa JP: Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 23: 206-215, 2003. (Pubitemid 36008514)
16. Heard E, Rougeulle C, Arnaud D, Avner P, Allis CD and Spector DL: Methylation of histone H3 at Lys-9 is an early mark on the X chromosome during X inactivation. Cell 107: 727-738, 2001. (Pubitemid 34033666)
17. Mermoud JE, Popova B, Peters AH, Jenuwein T and Brockdorff N: Histone H3 lysine 9 methylation occurs rapidly at the onset of random X chromosome inactivation. Curr Biol 12: 247-251, 2002. (Pubitemid 34122383)
18. Nguyen CT, Weisenberger DJ, Velicescu M, et al: Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2′-deoxycytidine. Cancer Res 62: 6456-6461, 2002. (Pubitemid 35364106)
19. Schotta G, Lachner M, Sarma K, et al: A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 18: 1251-1262, 2004. (Pubitemid 38720593)
20. McCarty KS Jr, Miller LS, Cox EB, Konrath J and McCarty KS Sr: Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 109: 716-721, 1985. (Pubitemid 16237466)
21. Jones PA and Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev Genet 3: 415-428, 2002. (Pubitemid 34587077)
22. Hake SB, Xiao A and Allis CD: Linking the epigenetic 'language' of covalent histone modifications to cancer. Br J Cancer 90: 761-769, 2004. (Pubitemid 38406583)
23. Esteller M: Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298, 2007.
24. Ooi SK, Qiu C, Bernstein E, et al: DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448: 714-717, 2007. (Pubitemid 47236857)
25. Cedar H and Bergman Y: Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304, 2009.
26. Shah MY and Licht JD: DNMT3A mutations in acute myeloid leukemia. Nat Genet 43: 289-290, 2011.
27. Northcott PA, Nakahara Y, Wu X, et al: Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat Genet 41: 465-472, 2009.